Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
AstraZeneca
Healthtrust
Covington
Queensland Health
McKesson
Julphar
Baxter
Cantor Fitzgerald

Generated: August 23, 2017

DrugPatentWatch Database Preview

Delcor Asset Corp Company Profile

« Back to Dashboard

What is the competitive landscape for DELCOR ASSET CORP, and what generic and branded alternatives to DELCOR ASSET CORP drugs are available?

DELCOR ASSET CORP has seventeen approved drugs.



Summary for Applicant: Delcor Asset Corp

Patents:0
Tradenames:7
Ingredients:6
NDAs:17
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Delcor Asset Corp
KENACORT
triamcinolone
TABLET;ORAL011283-008Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
KENACORT
triamcinolone
TABLET;ORAL011283-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
KENALOG-H
triamcinolone acetonide
CREAM;TOPICAL086240-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
KENALOG
triamcinolone acetonide
LOTION;TOPICAL011602-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
MYCOSTATIN
nystatin
CREAM;TOPICAL060575-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
MYCOLOG-II
nystatin; triamcinolone acetonide
CREAM;TOPICAL060576-002May 1, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
KENACORT
triamcinolone diacetate
SYRUP;ORAL012515-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
MYCOSTATIN
nystatin
TABLET;ORAL060574-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
KENACORT
triamcinolone
TABLET;ORAL011283-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
KENALOG
triamcinolone acetonide
LOTION;TOPICAL084343-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Delcor Asset Corp

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Delcor Asset Corp
KENALOG-H
triamcinolone acetonide
CREAM;TOPICAL086240-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Julphar
Accenture
Fuji
Teva
Cipla
Cantor Fitzgerald
Boehringer Ingelheim
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot